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Cystic fibrosis (CF), which is caused by mutations in
the gene encoding the cystic fibrosis transmembrane
conductance regulator (CFTR), is characterized by
multiorgan pathology that begins early in life. To
better understand the initial stages of disease, we
studied the gastrointestinal pathology of CFTR/
pigs. By studying newborns, we avoided secondary
changes attributable to environmental interactions,
infection, or disease progression. Lesions resembling
those in humans with CF were detected in intestine,
pancreas, liver, gallbladder, and cystic duct. These
organs had four common features. First, disease was
accelerated compared with that in humans, which
could provide a strategy to discover modifying fac-
tors. Second, affected organs showed variable hyper-
plastic, metaplastic, and connective tissue changes,
indicating that remodeling was a dynamic component
of fetal life. Third, cellular inflammation was often
mild to moderate and not always present, which raises
new questions as to the role of cellular inflammation in
early disease pathogenesis. Fourth, epithelial mucus-
producing cells were often increased, producing a strik-
ing accumulation of mucus with a layered appearance
and resilient structure. Thus, mucus cell hyperplasia
and mucus accumulation play prominent roles in
early disease. Our findings also have implications for
CF lung disease, and they lay the foundation for a
better understanding of CF pathogenesis. (Am J
Pathol 2010, 176:1377–1389; DOI: 10.2353/ajpath.2010.090849)
Early in the twentieth century, pioneering researchers
established a framework for understanding the pathology
of cystic fibrosis (CF). In 1905, Landsteiner described
meconium ileus associated with pancreatic disease in a
newborn.1 By 1938, Andersen documented the common
pancreatic pathology in a cohort of CF patients and ap-
plied the term “cystic fibrosis of the pancreas” in her
description of 49 pediatric cases.2 Later, Farber recog-
nized significant involvement of multiple organs by a
tenacious, thick mucus, which led to his descriptive ter-
minology of “mucoviscidosis.”3,4 Almost a decade later,
Bodian published a seminal record of young pediatric CF
disease with detailed medical history and images that
arguably have not been equaled since.5 At that time, CF
was a pediatric disease with a high mortality, and the
study of pathological changes in CF tissues from young
infants and children5–8 generated hypotheses about
pathogenesis and therapies. Fortunately, that era has
passed with advances in medical management that have
improved median lifespan to more than 37 years.9,10
Hence, early lesions are now rarely accessible for patho-
logical examination and study.
It has been twenty years since the gene responsible for
CF was identified and more than fifteen years since the
first cystic fibrosis transmembrane conductance regula-
tor (CFTR/) mouse models were developed.11,12 Al-
though much progress has been made,9,13,14 there re-
mains a lack of understanding regarding the pathogenic
events that orchestrate disease in affected organs. To
provide a model in which to investigate CF, we recently
developed CFTR/ pigs and found that they display
gastrointestinal lesions consistent with CF disease.15,16
These pigs provide several advantages for pathology
studies and avoid limitations of human studies. We are
able to study newborn CFTR/ pigs before they develop
secondary changes attributable to interactions with their
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environment and infection. We can also avoid changes
attributable to severe terminal disease and postmortem
alterations. In addition, pathological data from humans
can be skewed by many factors, including toward the
most severe cases that come to autopsy, whereas with
newborn pigs we have the opportunity to assess the
spectrum of disease at one point in time. Thus, the goal of
this study was to assess the gastrointestinal pathology in
newborn CFTR/ pigs to provide insight into the early
changes of the disease.
Materials and Methods
Animals
All studies were approved by the University of Iowa An-
imal Care and Use Committee. Neonatal pigs (eight to
twenty-four hours old) were used for the study to minimize
environmental influences on tissues. Littermates from
CFTR/matings were obtained from Exemplar Genetics
(Sioux Center, IA). Piglets included CFTR/ (n  12),
CFTR/ (n  12), and CFTR/ (n  26) genotypes. For
determining the frequency of fetal perforation/peritonitis,
we examined the necropsy records of the 26 CFTR/
pigs along with the necropsy records of six additional
CFTR/ pigs whose tissues were not available for sub-
sequent histopathology.
Tissues and Pathology Examination
After euthanasia (Euthasol, Virbac, Fort Worth, TX), all
tissues were collected and immersed in fixative for 48 to
96 hours depending on tissue size, routinely processed,
embedded, sectioned (4 micrometers), and stained with
hematoxylin and eosin. Some sections were further
stained with periodic acid-Schiff (PAS) stain, which de-
tects neutral mucins, Alcian Blue/Pyronine Y (ABPY)
stain, which detects acidic mucins, or Masson trichrome
stain for identification of collagen deposition.16–18 All tis-
sues were examined by a pathologist (D.K.M.) familiar
with the species and CF. Human CF tissues samples
were identified from autopsy archival material in the De-
partment of Pathology, University of Iowa.
Morphometry
After histopathological examination, high-resolution digital
images were collected (DP71 digital camera and BX41
microscope, Olympus, Center Valley, PA) and these im-
ages were morphometrically analyzed with MicroSuite Pa-
thology Edition software (Olympus, Center Valley, PA).
Thickness of the intestinal smooth muscle layer (ie, tunica
muscularis) was consistently defined as the minimal di-
ameter of the layer (to avoid sectioning artifacts) in tissue
cross-sections and reported in micrometers. Pancreas
parenchyma was assessed by low magnification exami-
nation, and the lobular area of pancreatic parenchyma
(containing a mixture of exocrine with endocrine tissue)
was defined, area quantified, and then reflected as a
percentage of the total pancreatic area. For gallbladder
diameter assessment, all sections were consistently
sectioned in the same plane at the widest portion of the
intact gallbladder. To account for “collapsed” gallblad-
ders postsectioning, and to provide consistent/repro-
ducible measurements, the histopathological circum-
ference of the gallbladder lumen was enumerated by
software analysis and the diameter calculated (diame-
ter  circumference/).
Statistics
Analysis for genotypic (CFTR/, CFTR/, and CFTR/)
differences was performed using one-way analysis of vari-
ance, and intergroup post tests were made with a Bonfer-
roni multiple comparison test. Statistical analysis was per-
formed using Prism software (Graphpad, La Jolla, CA).
Results
Intestinal Disease
Meconium Ileus Obstruction
Meconium ileus involves an obstruction of the intestine
that occurs in about 15% of CF neonates and may be
detected as early as 17 weeks gestation.19–22 In all neo-
natal CFTR/ pigs, meconium ileus was present (Figure
1, A and B). The site of obstruction ranged from the distal
jejunum to the proximal spiral colon (Figure 1, A–C), an
elongated and coiled equivalent to the human ascending
colon. This distribution is similar to that reported in hu-
mans with meconium ileus.23 In CFTR/ pigs, the site of
obstruction consisted of a dilated meconium-filled prox-
imal bowel segment, a transition zone (abrupt to grad-
ual), and a distal bowel that was diffusely small in caliber
(Figure 1A) and variably filled with white to gray-green
firm cords of mucus. The small caliber distal bowel was
firm and lacked pliability compared with normal bowel
and may have contributed to the intestinal obstruction. In
addition, CFTR/ meconium was sticky and adherent to
the intestinal wall, and it may have contributed to the
formation of the obstruction.
Inflammation was not observed in CFTR/ intestine
compared with controls, except as a secondary feature
near sites of perforation and necrosis (Figure 1D); there,
neutrophils were the predominant leukocytes in acute
lesions. Studies of human CF have reported intestinal
perforation, peritonitis, and/or volvulus as in utero and
postnatal complications of meconium ileus.24,25 Likewise
in CFTR/ pigs, we observed intestinal perforation and
peritonitis that occurred in the fetal and early postnatal
period usually in severely dilated small intestine. Fetal
perforation was uncommon (2 of 32, 6%) and when
present was characterized by fibrin, adhesions, exuda-
tive fluid filling the abdomen, and granulomatous perito-
nitis centered on meconium material.
The extent of mucus production depended on the in-
testinal location. In the spiral colon distal to the obstruc-
tion, the lumen contained mucocellular accumulations
(Figure 1E), and the adjacent colonic glands were often
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distended by stringy mucus (Figure 1, E and F). The
CFTR/ colonic epithelium showed mild to moderate
mucinous hyperplasia, especially toward the surface ep-
ithelium, and the cells were relatively stout and distended
by mucus (Figure 1F). The presence of luminal mucus
and epithelial mucinous change in the colon did not
appear to depend on the proximity to the site of intestinal
obstruction. The histochemical staining quality of the
CFTR/ mucus often showed enhanced production of
sulfated mucus (Figure 1, E and F; red coloration) similar
to that reported in human CF.26 The CFTR/ colon with
mucinous hyperplasia lacked detectable inflammation.
In the proximal small intestine, focal thin strands of
eosinophilic mucus were uncommonly detected within
the crypts and between villi with some minor focal luminal
accumulation. Mucinous hyperplasia in the small intes-
tine proximal to the obstruction was lacking to focal and
mild. Bru¨nner glands of the duodenum were focally ec-
tatic, filled by wispy mucus, and had a thin epithelial
border (Figure 2A). In the small intestine distal to the
obstruction, luminal mucus was more readily detected
and combined with sloughed cells in a layered fashion to
form mucocellular cords (pellets; Figure 2B). The pres-
ence of these cords did not appear to be dependent on
the proximity to the obstruction. Patches of meconium
were occasionally intermixed with these mucocellular
cords, which sometimes dislodged from the intestinal
wall to accumulate distally, especially in the hours after
CFTR/ pigs consumed their first meal. The morpholog-
ical appearance of these dislodged cords (Figure 2B,
right panel) was similar to their appearance before dis-
lodgement (Figure 2B, left panel), suggesting resilience
in physical structure. The proximal spiral colon was a
common site of accumulation for dislodged cords, which
in some cases formed large luminal masses (Figure 2, C
and D). These large aggregates occasionally caused
severe distension, which led to necrosis and perforation
in CFTR/ pigs. Although the small intestine is the most
Figure 1. Meconium ileus in CFTR/ intestine.
A: Meconium-filled bowel (asterisks) was prox-
imal to the obstruction interface (black arrow);
distal to the interface, the bowel was hypoplastic
(white arrow). Scale bar  2.45 cm. B: Meco-
nium (white asterisks) dilated the spiral colon
(ventral view) and cecum (Ce) proximal to the
obstruction interface (black arrow). Microcolon
appeared distally. Scale bar  1.34 cm. C: Sites
of obstruction in CFTR/ pigs were distributed
on either side of the ileocecal junction extending
from the small intestine (proximal) into the spiral
colon (distal). D: CFTR/ jejunum showing lu-
minal meconium (asterisk) causing severe dis-
tension and mucosal thinning with focal hemor-
rhage, necrosis (arrows), and neutrophilic
inflammation, HE stain. Scale bars 0.29 mm. E:
CFTR/ spiral colon had luminal mucus ac-
cumulation with hyperplastic mucus-produc-
ing cells especially noticeable compared with
CFTR/ along the surface epithelium (inset
boxes, see F). ABPY stain. Scale bars  117
m. F: CFTR/ spiral colon glands were dis-
tended by stringy mucus that extends from
stout mucus-producing cells in the epithelium,
ABPY stain. Scale bars  69 m.
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common site of perforation in CF infants (and CFTR/
pigs), colonic perforations have been reported to occur in
children due to numerous cords filling the colon and
causing direct irritation and injury.27
We observed no difference between CFTR/ and
CFTR/ animals at any site along the intestinal tract or in
any of the other organs we describe below. We also
observed no differences between lesions in male and
female piglets.
Additional Intestinal Lesions
CF infants are prone to intestinal atresia with a 200-
fold increased risk compared with the general Caucasian
population.23,28 Atresias were also detected in CFTR/
pigs (Figure 2E, left panel). Stenotic and atretic segments
of bowel were commonly detected distal to the site of
meconium obstruction. Most CFTR/ pig atresias were
small gauged (less than 2 mm outer diameter), continu-
ous with adjacent bowel and had rare serosal twisting.
The atresia formation was similar to that described for CF
infants (Figure 2E, right panel).5,29
The mechanisms that produce atresia remain uncer-
tain. Atresias might result from in utero vascular com-
promise caused by lesions such as volvulus.21,29,30
Although we did not observe overt volvulus in the
CFTR/ pigs, it is possible that obstruction predis-
posed to secondary vascular compromise, manifested
as serosal twisting at birth. It is also possible that
intestine distal to the site of obstruction failed to de-
velop normally because of a lack of mechanical dis-
tention by luminal contents or because obstruction
prevented distal delivery of luminal contents that were
required for intestinal growth.31
Diverticulosis has been reported in the appendix and
colon of CF patients,32,33 and George33 found that CF
patients had a 7- to 14-fold increased incidence of diver-
ticulosis of the vermiform appendix (median age 13
years, including one infant). Histologically, the lesions
were classified as acquired pulsion or pressure type
diverticula. The pathogenesis was proposed to result
from increased pressure/distension by luminal material
and concurrent smooth muscle hypertrophy. Increased
intraluminal pressure may then lead to herniation of the
mucosa through the weakest part of the muscular wall at
sites of vascular penetration along the mesenteric bor-
der.33,34 Diverticulosis was a common intestinal lesion in
CFTR/ pigs. It appeared as saccular bulges along the
mesenteric border of dilated bowel (Figure 3A). Divertic-
ulosis usually occurred in the meconium-filled jejunum
when there was severe obstruction. Histologically, intes-
tinal diverticula were composed of tunica mucosa and
submucosa that were herniated through a hypertrophic
tunica muscularis (Figure 3A, right panel). In fact, the
tunica muscularis was hypertrophied throughout the in-
testinal tract including the duodenum and the spiral colon
(Figure 3A, right panel, and Figure 3B). In pathology
studies of CF infants, the tunica muscularis has also been
described as “well-formed” to “hypertrophic.”5,8
A review of the literature did not identify reports of
jejunoileal diverticula (excluding Meckel’s diverticula)
in CF. Although this may reflect the true clinical situa-
tion, some have suggested the overall incidence of
diverticula may be under-represented because inci-
Figure 2. Mucus accumulation and atresia in CFTR/ intestine. A: Duodenal Bru¨nner glands were focally distended by stringy mucus (asterisk) with flattening
of adjacent epithelium. HE stain. Scale bars  80 m. B: Distal to the obstruction interface, mucocellular cords (asterisks) filled the CFTR/ intestinal lumen
(left panel) and sometimes became dislodged from the intestinal wall to aggregate (right panel) distally in the bowel (arrow). HE stain. Scale bars  1.2 mm.
C: Cross section of a distended CFTR/ spiral colon filled with large aggregates of mucocellular cords (asterisks) that retained their morphology from the small
intestine (see also B, left panel). ABPY stain. Scale bars  1.7 mm (left panel) and 0.7 mm (right panel). D: Aggregates of mucocellular cords (asterisks)
distended a loop of CFTR/ spiral colon and were detectable in cross section (arrow). Scale bar  11.1 mm. E: Segmental atresia (arrows) was present distal
to the obstruction interface in the CFTR/ pig (Scale bar  11.5 mm) and is similar to what Bodian described in CF infants.5 Reprinted from Fibrocystic Disease
of the Pancreas: a Congenital Disorder of Mucus Production-Mucosis, Martin Bodian, Page 84, Copyright 1953.
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dental identification often requires high vigilance dur-
ing examination.33,34 In people without CF, jejunoileal
diverticula are typically observed in elderly patients.34
Pigs have been reported to have smooth muscle hy-
pertrophy and diverticulosis of the small intestine as
incidental findings at necropsy and rarely as a cause of
perforation. A genetic predisposition has also been
speculated for some pig breeds.35 Consistent with
the proposed pathogenesis in humans, diverticula in
CFTR/ pigs may have occurred in the dilated meco-
nium filled bowel because of the combined increased
intraluminal pressure and hypertrophic smooth muscle
during fetal life.
Pancreatic Disease
The pancreas is affected in 85% to 90% of CF pa-
tients,36,37 and pancreatic lesions have been reported in
neonates and fetuses as young as seventeen weeks
gestation. These lesions consist of luminal dilation of
acini/ducts by eosinophilic zymogen material. With in-
creased luminal material there is progressive thinning of
the lining epithelium, and mucus metaplasia may be de-
tected in the larger ducts.20,38,39 In fact, the classic lesion
of the CF pancreas consists of dilated (“cystic”) ducts
filled by stringy zymogen material and mucus.2,4,5,40 In
neonatal CFTR/ pig pancreas, the exocrine tissue con-
tained zymogen-rich acini (Figure 4A), and on occasion,
we observed ducts filled with normal appearing zymogen
secretions. Mucus cells were typically restricted to large
ducts (Figure 4A), and small submucosal glands were
noted in the terminal duct near the duodenum.
In CFTR/ pigs, pancreatic lesions were ubiquitous
and there was a range in severity of exocrine tissue
destruction (Figure 4B). Endocrine tissue was spared
from the destruction and appeared morphologically in-
tact.16 Acinar cells were reduced in number and had
decreased amounts of cytoplasmic zymogen granules.
Zymogen secretions often filled the acinar and ductular
lumens of CFTR/ pancreata (Figure 4C). In some
ducts, stringy zymogen material was surrounded by mild
to moderate amounts of mucus (Figure 4C). With in-
creased filling of acinar and ductal lumens by altered
zymogen material, the adjacent acinar and ductular ep-
ithelium became thinner. Adjacent to the residual exo-
crine tissue were pools of eosinophilic zymogen material
that appeared to be free within the interstitium (Figure
4C). The interstitial zymogen material was morphologi-
cally degenerate (eg, hyalinized, fragmented) compared
with zymogen material still confined by an epithelial bor-
der. Because the pancreas is not easily accessible to bi-
opsy and tissues from young children with CF are no longer
common, we examined autopsy tissue from an adult with
Figure 3. Diverticuli and smooth muscle thickening in CFTR/ intestine. A:
Diverticula (asterisks and white arrows) formed along the mesenteric
border and were lined by a thin mucosa and submucosa, which herniated
through a thickened tunica muscularis (black arrows). Scale bars  3.8 mm
(left and middle panel) and 1.4 mm (right panel, HE stain). B: Tunica
muscularis of the CFTR/ pig intestine was generally hypertrophied, in-
cluding in the duodenum (left, P  0.01 versus CFTR/, P  0.05, versus
CFTR/) and the spiral colon (right, P  0.01 versus CFTR/, P  0.001
versus CFTR/, one-way analysis of variance with Bonferroni post test).
Figure 4. Exocrine pancreatic destruction in CFTR/ pigs. A: CFTR/ pig
pancreas was rich in exocrine tissue (left panel) with large ducts (right
panel) that were partially filled with normal zymogen secretions (white lines
are sectioning artifact). Mucus cells were uncommon in the epithelium
(arrows and inset). HE stain. Scale bars  72 m. B: CFTR/ pancreata
had reduced lobular parenchyma (P  0.001 vs. CFTR/ and CFTR/,
one-way analysis of variance with Bonferroni post test). Scale bar  mean.
C: Degenerative pools of eosinophilic zymogen secretions were detected
“free” within the interstitium (black arrows). Within dilated ducts, centrally
oriented zymogen secretions (asterisk) were often surrounded by stringy
mucus (white arrows). HE stain. Scale bars  37 m. D: Adult human CF
pancreas (with autolysis making some features less appreciable) showed
similar degenerative pools of interstitial zymogen secretions (arrows, left
panel) and similar secretions (asterisk) were detected in dilated ducts
surrounded by mucus (arrows, right panel). HE stain. Scale bars  35 m
and 53 m (left and right panel, respectively).
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clinically mild CF disease. We found remnant exocrine tis-
sue that had zymogen material in a similar interstitial distri-
bution with degenerative characteristics as that in CFTR/
pigs (Figure 4D). In both pigs and humans, the interstitial
pools of zymogen material elicited minimal direct cel-
lular inflammatory response even with the appearance
of morphological degeneration. The loss of exocrine
tissue was replaced by increased connective tissue in
the pancreata of CF infants41,42 and CFTR/ pigs.
In addition, foci of duct proliferation were detected in
exocrine tissue (Figure 5A), especially noted in pancre-
ata with more severe exocrine destruction. In her detailed
description of CF pancreas pathology, Sturgess38 noted
that proliferation of ducts was common in CF infant pan-
creas. Recent evidence suggests that ductular prolifera-
tion may be a manifestation of acinar to ductular meta-
plasia, a reaction to pancreatic injury.43,44 An additional
mechanism of degenerative change seen in a few rare
ducts included purple granular material consistent with dys-
trophic calcification (Figure 5A). In pancreata with mild dis-
ease, mucinous metaplasia of ducts was only observed in
uncommon large ducts. This is in contrast to pancreata with
severe destruction where mucinous metaplasia was espe-
cially prominent and seen in large, medium, and small
ducts (Figure 5B). The proliferative mucus cells lining ec-
tatic ducts were often plump and full of mucus.
In CF infants, pancreas inflammation was described by
Andersen2 as mild with a small number of neutrophils and
macrophages in the acinar tissue and scattered mono-
nuclear aggregates in the interstitium. This was also the
case in porcine CFTR/ pancreas. Although all CFTR/
pancreata had detectable cellular inflammation, most of
this was patchy in distribution with increased detection
noted with progressive disease severity. Scattered
neutrophils and macrophages were detected princi-
pally within dilated acini (Figure 5C, left panel) and
ectatic ducts. There, they infrequently formed loose
cellular aggregates, which morphologically could be
described as a “pancreatitis.” Interstitial inflammation
usually consisted of scattered lymphocytic aggregates
that became more prominent around ectatic ob-
structed ducts in areas of severe pancreatic destruc-
tion (Figure 5C, right panel).
Figure 5. Duct proliferation, mucus accumula-
tion, and inflammation in CFTR/ pancreas. A:
Foci of proliferative (left panel, arrows) and
dilated ducts were common in CFTR/ pancre-
ata. Dystrophic calcification was rarely detected
(right panel, arrow). HE stain. Scale bars 
110 m and 55 m (left and right panel, re-
spectively). B: In severely disease pancreata, in-
creased mucinous metaplasia of ducts was de-
tected. Note the large mucus cells (arrows)
circumferentially lining variably sized ducts that
are moderately distended by stringy mucus. PAS
(left panel) and ABPY (right panel) stains.
Scale bars  55 m. C: Acini and ducts dilated
by zymogen material had scattered infiltrates of
neutrophils (arrows, left panel) and to a lesser
extent, macrophages. Severe exocrine destruc-
tion was often associated with interstitial lym-
phoid aggregates (arrows, right panel) adja-
cent to dilated, cyst-like ducts (black asterisk).
HE stain. Scale bars 36 m (left panel) and 55
m (right panel).
1382 Meyerholz et al
AJP March 2010, Vol. 176, No. 3
Liver Disease
Liver disease is now the second leading cause of CF
mortality.45–47 Focal biliary cirrhosis (FBC), the hallmark
lesion in patients with CF, is characterized by biliary
proliferation, fibrosis, and inflammation.2,5,41,48,49 FBC
may progress to bridging and multilobular cirrhosis in up
to 17% of patients, with most being diagnosed before
age fourteen.50 In CFTR/ pigs, biliary proliferation was
the most readily detected parameter of FBC (Table 1).
Fibrosis (fibroplasia) was typically mild in severity and
usually adjacent to proliferative ducts. Lymphocytic in-
flammation, when present, was detected adjacent to pro-
liferative ducts and ranged from scattered cells to mod-
erate cellular aggregates expanding the triad. Bridging of
triads by these lesions was rare, but when present was
accentuated by biliary proliferation (Figure 6A, top left
panel) with fibroplasia and inflammation—all suggestive
of early multilobular change (Figure 6B, Table 1). In the
pig, peribiliary glands appear principally in larger ducts,
thus should mucus obstruction occur here, it could result
in proliferation of the smaller bile ducts. Uncommonly,
alterations were found in biliary ducts including mucinous
change (increased epithelial mucus staining), obstruc-
tion by mucocellular plugs (inflammatory cells, cell de-
bris, and variable mucus depending on the size of duct),
and concretions of bile (choleliths; Figure 6A).
There were no detectable differences between CFTR/
and CFTR/ livers in steatosis, hemosiderosis, or cho-
lestasis. Likewise, in CF infants, steatosis is generally
considered to be secondary to the various chronic met-
abolic changes in postnatal life.51 Independent of geno-
type, neonatal pigs had multifocal cellular aggregates of
hematopoietic cells (ie, extramedullary hematopoiesis) in
the liver (Figure 6C). Cellular aggregates were often
grouped according to lineage, they were localized in the
parenchyma and less commonly adjacent to hepatic triads,
and they required differentiation from inflammation.
Gallbladder Disease
Gallbladder lesions are reported in 20% to 30% of CF
infants and typically consist of a small gallbladder (mi-
crogallbladder) with proliferative epithelium that some-
times form mucosal folds or “cysts.”2,5,51–53 The CF infant
gallbladder can also manifest features such as luminal
mucus, thickened bile, choleliths, and/or cholecystitis.52
Incidentally, most CF patients lack clinical consequences
of microgallbladder.51 All CFTR/ pigs had a microgall-
bladder, which was readily apparent at necropsy and
histopathology (Figure 7, A and B). It resembled that
seen in humans with CF (Figure 7A, right panel).54
We stained the gallbladder with PAS, which detects
neutral mucins and ABPY histochemical stains, which
detect sialylated (blue), sulfated (red), or mixed (purple)
acidic mucins.17,18 The CFTR/ gallbladders had minor
staining (Figure 8A, top panels), whereas the gallbladder
epithelium of CFTR/ pigs showed diffuse epithelial mu-
cinous change in most cases (Table 1), although the
extent of luminal mucus accumulation varied. In the
CFTR/ gallbladder, the PAS stain accentuated concen-
trically lamellar striations in the mucus that were parallel
to the epithelial surface and that were reminiscent of the
growth rings in a tree (Figure 8A, bottom left). CFTR/
gallbladders stained with ABPY showed a heterogeneous
cellular production of sialylated, sulfated, and some
mixed acidic mucus with a detectable preference toward
sulfated mucus. This histochemical stain also highlighted
distinct ribbons of mucus extending out perpendicularly
from the epithelium. These ribbons often retained their
form and structure with minimal amalgamation of adja-
cent mucus ribbons (Figure 8A, bottom right). It was
difficult to obtain serial sections because of frequent
tissue folds associated with sectioning gallbladders filled
with mucus plugs. When available, serial sections using
both stains demonstrated similar morphological features
(Figure 8B).
Additional microscopic changes in the CFTR/ gall-
bladder included luminal obstruction by a mixture of mu-
cus and altered bile with proliferative mucosal folds
(Figure 9A). Occasionally, small focal aggregates of neu-
trophils were detected within the luminal mucus near the
epithelium. Mild mononuclear inflammation was sometimes
detected in the lamina propria and connective tissue of the
gallbladder wall, which also had mild to moderate thicken-
ing by increased collagen and smooth muscle. The appar-
ent discrepancy between the severity of the gallbladder
disease and the milder liver disease in neonatal CFTR/
pigs could suggest that their pathogenesis is not sequential
or directly related. Alternatively, given the focal nature of CF
liver lesions (eg, FBC), we cannot rule out that every
CFTR/ liver may have some degree of FBC that is not
readily detectable in routine tissue sampling.
Cystic Duct Disease
The cystic duct connects the gallbladder to the common
bile duct. The occurrence of cystic duct lesions paralleled
gallbladder lesions and included mucinous change with
Table 1. Liver and Gallbladder Lesion Parameters according to Pig Genotype
Genotype
Biliary
proliferation Fibrosis Inflammation
Triad
bridging
Extra-medullary
hematopoiesis Steatosis
GB mucinous
change
CFTR/ 0% (1/12) 0% (0/12) 0% (0/12) 0% (0/12) 100% (12/12) 17% (2/12) mild 8% (1/12) mild
CFTR/ 0% (0/12) 0% (0/12) 0% (0/12) 0% (0/12) 92% (11/12) 0% (0/12) 0% (0/12)
CFTR/ 58% (15/26) 42% (11/26) 54% (14/26) 8% (2/26) 100% (24/24) 8% (2/26) mild 94% (17/18)
GB indicates gallbladder.
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obstruction and stenosis.5,52,53 Bodian5 noted that in four-
teen cases of CF gallbladder disease, the cystic duct was
consistently obstructed, yet the extrahepatic ducts were
patent. Similarly, CFTR/ pig cystic ducts were consis-
tently obstructed by mucocellular material (Figure 9B), bile,
and at times proliferative mucosa folds that formed cystic-
like structures containing luminal material. Inflammatory
changes were similar to that seen in the gallbladder. We
Figure 6. Rare lesions in CFTR/ liver and in-
cidental findings in all genotypes. A: Infrequent
to rare findings in CFTR/ liver. Biliary tracts
had expansive and florid proliferation (arrow,
top left panel, MT stain) with adjacent fibrosis
(blue) and inflammation. Intrahepatic ducts had
mucinous change (arrow, top right panel, PAS
stain), mucocellular plugs (arrow, left bottom
panel, HE stain), or choleliths (arrows, right
bottom panel, HE stain). Scale bars  55 m.
B: Widespread bridging (arrowheads) of triads
by biliary hyperplasia, inflammation, and fibro-
sis (blue staining) was rarely detected in
CFTR/ pigs. Scale bars  220 m. In these
cases, the serosal surface was often retracted
causing a slightly irregular surface (arrows, in-
set, Scale bars  197 m). MT stain. C: Foci of
extramedullary hematopoiesis were composed
of erythroid, granulocytic, and megakaryocytic
lineage aggregates (respective panels) in liver of
all genotypes. HE stain. Scale bars  17.5 m.
Figure 7. Microgallbladder in CFTR/ pigs. A:
CFTR/ pig gallbladders (asterisk, Scale bar
10.5 mm) were typically distended with bile,
whereas microgallbladder (arrows, Scale bar 
7.4 mm) was seen in the CFTR/ pig. Right
panel shows microgallbladder from infant with
CF as reported by Bodian.5 Reprinted from Fi-
brocystic Disease of the Pancreas: a Congenital
Disorder of Mucus Production-Mucosis, Martin
Bodian, Page 112, Copyright 1953. B: Histolog-
ical measurements showed that porcine
CFTR/ gallbladder was smaller than CFTR/
or CFTR/ (P  0.001 respectively, one-way
analysis of variance with Bonferroni post test,
Scale bar  mean).
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examined the common bile duct at necropsy in a few cases,
and no obstruction was detected.
Discussion
Disease Severity in Humans with CF and
CFTR/ Pigs
The most prominent difference between disease in new-
born babies with CF and newborn CFTR/ pigs was that
the disease was more severe in the pigs. For example,
meconium ileus occurred in 100% of the pigs, but 15%
of humans19–22; gallbladder abnormalities were present
in 100% of CFTR/ pigs, but 20% to 30% of hu-
mans2,51–53; up to 42% of newborn CFTR/ pigs had
lesion parameters consistent with FBC, whereas14% to
43% of CF infants show similar morphological chan-
ges2,5,48,52; and all CFTR/ pig pancreata (100%) were
readily distinguished from controls by gross inspection at
necropsy, whereas in CF infants, morphological detec-
tion of pancreatic disease is up to 93% successful only
when using extensive histological examination and quan-
titative morphometric analysis.55
What accounts for the increased disease severity in
the CFTR/ pigs? There are several considerations.
First, the pigs have a null mutation, whereas the majority
of humans have at least one F508 or one missense
mutation, either of which might generate a very small
amount of CFTR function. Perhaps only a small amount of
CFTR function is sufficient to slow the progression of
disease in humans relative to CFTR null pigs. Consistent
with this possibility, many aspects of the disease, includ-
ing meconium ileus, have a significant genotype/pheno-
type correlation.56 Second, genetic modifiers might be
distinct in humans and these pigs. Genetic modifiers are
known to influence the course of CF in humans.56–59
Although not inbred to the extent defined for mice, the
CFTR/ pigs are currently much more inbred than hu-
mans, and it is possible that by out-breeding the pigs we
will be able to modify their phenotype. Consistent with
this speculation, the severity of pathological changes
varied between individual animals. Furthermore, study of
human CFTR genotype to phenotype correlation in twins
suggests modifier genes play an important role for both
causative and preventive effects.56 Third, it is possible
that humans express another anion channel that com-
pensates, at least in small measure, for the loss of CFTR
and thereby partly mitigates the pathological develop-
ments. In this regard, it has been hypothesized that an
alternative Cl channel partly replaces CFTR function in
CFTR/ mice.60 Fourth, it has been hypothesized that a
misfolded CFTR protein, especially CFTR-F508, might
elicit an unfolded protein response that contributes to CF
disease in humans.61 Because CF disease tends to be
milder in humans than in pigs, our data suggest that if an
unfolded protein response contributes to differences in
severity between the species, then it may attenuate dis-
ease severity. Fifth, it seems unlikely that anatomical
differences between the species (eg, the spiral colon in
pigs versus the ascending colon in humans) are entirely
responsible because differences in severity between the
Figure 9. Gallbladder and cystic duct lesions. A: The CFTR/ gallbladder
mucosa sometimes formed folds of proliferative epithelium to form cyst-like
structures (arrows) along the mucosa. HE (left) and PAS (right) stain. Scale
bars  550 m. B: CFTR/ cystic ducts were variably obstructed (asterisk)
and stenotic compared with controls. HE (left and middle) and PAS (right)
stains. Scale bars  116 m.
Figure 8. Mucus cell proliferation and mucus accumulation in CFTR/
gallbladder. A: Nominal apical mucus staining in CFTR/ gallbladder epi-
thelium (top panels, Scale bars  38 m). CFTR/ gallbladder typically
had diffuse mucinous change (bottom panels, Scale bars  26 m) with
contrasting morphological characteristics of mucus including lamellar stria-
tions (see white dotted lines) parallel to the epithelium (left panel, PAS
stain) and ribbons of resilient mucus perpendicular to the epithelium (right
panel, ABPY stain). B: Serial sections of CFTR/ gallbladder contained
similar morphological changes. Scale bars  32 m.
GI Pathology in a Porcine Model of CF 1385
AJP March 2010, Vol. 176, No. 3
species occurred in multiple organs. In fact, the greater
severity of disease in pigs versus humans suggest that
whatever the cause, it likely involves a global difference
in phenotype of CFTR-deficient epithelia that is mani-
fest in many organs before birth. The same is likely to
be true in mice. Although CFTR/ mice do not develop
classical meconium ileus like humans with CF, at an early
age, most CFTR/ mice develop intestinal mucus ob-
struction. Histopathological changes in the pancreas,
liver, and gallbladder are nominal and may show some
disease progression in advanced age.60,62 We propose
that comparing the pathophysiological features of these
three species may yield novel insight into the varying
lesion severity (pig  human  mice) and hence, the
pathogenesis of CF disease.
Tissue Remodeling and Mucus Accumulation
In general, affected organs in newborn pigs shared four
features: a) prominent epithelial mucus producing cells,
b) mucus accumulation, c) tissue remodeling, and d)
inflammation.
Epithelial Mucus Cells
Epithelia in the affected porcine organs often showed a
prominent increase in mucus cells. Mucinous epithelial
changes also occur in human tissues, which led Bodian5
to use the term “mucosis” to describe the changes in
various CF organs.
Mucus Accumulation
Accumulation of mucus in pancreatic ducts, gallblad-
der/cystic duct, and intestine was a consistent finding in
CFTR/ pigs. Likewise, early observations in CF infants
reported mucus accumulation as a common pathological
feature.3,4 The prominent mucus accumulation even
caused some early investigators to suggest the cause of
CF was a “mucinase deficiency.”4 In CFTR/ pigs, the
morphological character of the mucus was striking. The
concentrically lamellar striations of mucus (gallbladder,
pancreas ducts, and intestine) suggest that luminal ac-
cumulation formed by serial secretions. Consistent with
this speculation, the cytoplasm of mucus-producing cells
was usually distended with mucus suggesting that the
secretion process occurred at a modest rate that did not
deplete mucus from the cells.63 The mucus secretions
were also congealed and resilient, retaining a relatively
fixed macroscopic structure even when it migrated to a
new location. Whether the structure of the mucus was a
result of stasis attributable to a long-lasting obstruction or
a consequence of altered transepithelial ion transport
attributable to the lack of CFTR is unknown.
Tissue Remodeling
Tissue remodeling (eg, hyperplastic, metaplastic, con-
nective tissue changes) occurs as a response to chronic
disease, and many of these parameters were evident in
the neonatal CFTR/ organs. This implies that affected
tissues undergo significant remodeling even in the ab-
sence of environmental stimuli and that remodeling was a
dynamic component of fetal life.
Inflammation
Inflammation was detected in affected organs and was
characterized by mild to moderate patchy cellular infiltrates
adjacent to tissue lesions. The heterogeneous character
and localization of cellular infiltrates suggests that multiple
mechanisms/roles for inflammation may be at work.
The observations of increased epithelial mucus cells,
luminal mucus accumulation, tissue remodeling, and in-
flammation in multiple organs raise questions about the
pathogenic sequence of events. One idea might be that
inflammation triggered the conversion of a normal epithe-
lium to one with increased numbers of mucus cells, and
that they then secreted mucus that obstructed the lumen.
In that case, the stimulus for inflammation would presum-
ably be an inherent inflammatory state caused by lack of
CFTR; such an event has been postulated to exist in
CF.64 Although this study cannot fully address the role of
inflammation, our finding that profound intestinal muci-
nous change occurred in the absence of overt cellular
inflammation suggests that the presence of leukocytes
may not be a requirement for mucus production in all CF
tissues. Another possibility is that CF luminal mucus had
an intrinsic abnormal structure thereby causing tissue
injury and inflammation, which then further drove mucus
cell production. However, mucus cells are not routinely
present in epithelia at some anatomical sites (eg, small
ducts of the pancreas), and thus mucus production
would be absent or limited in the initial stages of the
disease pathogenesis. Nevertheless, the quantity of mu-
cus required for obstruction might be very small. A third,
related scenario is that defective electrolyte transport
attributable to loss of CFTR might change the consis-
tency of luminal secretions, thereby causing luminal mu-
coid plugs. Obstruction by altered secretions could
cause direct physical irritation of lining cells leading to a
cycle of mucinous metaplasia and further mucus produc-
tion. Consistent with this scenario, Tucker et al40 sug-
gested that altered zymogen secretions, rather than mucus,
caused the initial detectable obstruction of pancreatic
ducts; then, mucus metaplasia occurred and contributed
to the obstruction and exocrine atrophy. In addition, mu-
cinous metaplasia of the gallbladder epithelium is chro-
nologically correlated with gallstone formation, and the
physical presence of luminal gallstones may synergisti-
cally perpetuate metaplastic change in the gallbladder
epithelium.65 Studies of fetal CFTR/ pigs may shed
further light on some of these issues.
We also found that smooth muscle layers (eg, intestinal
tunica muscularis and gallbladder wall) were hypertro-
phic in CFTR/ pigs. Recently, CFTR has been detected
in smooth muscle, and functional studies suggested that
CFTR may play a role in their relaxation.66–68 Although
hypertrophy could be a secondary response of tissue
remodeling, it could also represent an intrinsic conse-
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quence due to loss of CFTR (ie, a persistent contracted
state). Thus, the absence of CFTR might cause altered
smooth muscle physiology that could contribute to CF
disease pathogenesis; however, the mechanism and ex-
tent of this effect remain elusive.
Relationship to Lung Disease
Even though CFTR is absent, the lungs of newborn
CFTR/ pigs appeared similar to those of their CFTR/
littermates.16 The discrepancy between the marked pathol-
ogy in the gastrointestinal organs described here and the
lack of pulmonary disease in newborn pigs may provide
some hints about CF pathogenesis and allows for some
speculation.
There are several feature(s) of the fetal lung that might
potentially prevent it from developing CF disease before
birth. The fetal lung is filled with liquid that originates from
respiratory epithelia and amniotic fluid.69 The composi-
tion of fetal lung liquid may be less prone to congealing
and causing obstruction than that in the ducts of gastro-
intestinal organs. Furthermore, impaired mucociliary
clearance is speculated to initiate CF airway disease,70
but in the relatively quiescent fetal lung, there is no apparent
requirement for mucociliary clearance. This situation con-
trasts with the functional activity of fetal gastrointestinal
organs, as hepatobiliary and pancreatic secretions are
constituents of meconium that is moved through the in-
testines via peristalsis. It is also possible that compared
with affected gastrointestinal organs, the composition or
concentration of material in fetal lung liquid is insufficient
to incite disease. Perhaps only after breathing air, when
the volume of airway surface liquid is very small, is ab-
normal transepithelial electrolyte transport able to modify
its composition in a way that initiates CF airway disease.
Comparing gastrointestinal organ pathology with the lack
of abnormalities in lungs also has implications for two other
aspects of CF that are well known to contribute to the
disease, submucosal glands and inflammation. Submuco-
sal glands have been hypothesized to generate mucus with
abnormal properties that contribute to lung disease.71 Mu-
cus metaplasia or hyperplasia with dramatic mucus accu-
mulation was detected in affected gastrointestinal organs.
In some cases (eg, pancreatic ducts and intestinal epithe-
lia), the luminal mucus derived from metaplastic surface
epithelia, and glands were not apparently required for dis-
ease. In contrast, the CFTR-rich Bru¨nner glands of the du-
odenal submucosa showed only minimal abnormalities
compared with other portions of the intestine. These obser-
vations lead us to wonder about the relative contribution of
mucus derived from submucosal glands versus surface
epithelia in the development of CF lung disease.
Inflammation was a feature in some affected gastroin-
testinal organs of newborn pigs, but not in the airways,
despite the fact that epithelia in all these organs express
CFTR. While it is certainly possible that lack of CFTR may
initiate an overly exuberant inflammatory response,72 our
results lead us to speculate that inflammation may not be
an inherent property of a CFTR/ cell or tissue in the
absence of a stimulus, but with a stimulus it plays an
important role in progression of the disease.73
This work sets the stage for studies that look forward as
animals mature and look backward to the fetus to assess
early pathogenic changes. Similarities and differences
between pathological changes in the pig, humans, and
mice should provide an opportunity to better understand
the pathogenesis of this devastating disease.
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